Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
Dollar change
Percentage change
Index- P/E28.18 EPS (ttm)2.74 Insider Own35.02% Shs Outstand145.16M Perf Week2.90%
Market Cap11.23B Forward P/E24.08 EPS next Y3.21 Insider Trans-0.11% Shs Float94.43M Perf Month-4.14%
Income401.60M PEG2.04 EPS next Q0.53 Inst Own78.65% Short Float3.41% Perf Quarter-7.60%
Sales3.00B P/S3.74 EPS this Y3.31% Inst Trans-10.56% Short Ratio3.36 Perf Half Y18.75%
Book/sh9.74 P/B7.93 EPS next Y20.36% ROA9.71% Short Interest3.22M Perf Year8.80%
Cash/sh2.34 P/C33.01 EPS next 5Y13.83% ROE30.94% 52W Range53.79 - 94.86 Perf YTD5.13%
Dividend Est.0.20 (0.26%) P/FCF62.00 EPS past 5Y20.48% ROI14.05% 52W High-18.56% Beta1.28
Dividend TTM0.20 (0.26%) Quick Ratio0.91 Sales past 5Y9.74% Gross Margin50.43% 52W Low43.61% ATR (14)2.75
Dividend Ex-DateJun 03, 2024 Current Ratio1.81 EPS Y/Y TTM30.37% Oper. Margin14.49% RSI (14)47.85 Volatility2.65% 3.63%
Employees9707 Debt/Eq1.03 Sales Y/Y TTM14.49% Profit Margin13.38% Recom2.00 Target Price85.70
Option/ShortYes / Yes LT Debt/Eq1.02 EPS Q/Q-32.68% Payout6.89% Rel Volume0.81 Prev Close76.70
Sales Surprise-1.12% EPS Surprise13.93% Sales Q/Q5.31% EarningsMay 17 BMO Avg Volume958.89K Price77.25
SMA201.78% SMA50-7.47% SMA2006.80% Trades Volume773,185 Change0.72%
Date Action Analyst Rating Change Price Target Change
Feb-14-24Upgrade JP Morgan Neutral → Overweight $60 → $90
Dec-19-23Initiated Wells Fargo Equal Weight $72
Dec-13-23Initiated Wolfe Research Outperform $80
Oct-21-22Initiated UBS Buy $70
Aug-22-22Upgrade Citigroup Neutral → Buy $70 → $80
Oct-15-21Resumed Cowen Market Perform $68
Jun-15-21Upgrade Cleveland Research Neutral → Buy
Feb-05-21Downgrade Wells Fargo Overweight → Equal Weight $50 → $55
Dec-02-20Initiated Goldman Sell $50
Nov-16-20Upgrade Wolfe Research Underperform → Peer Perform
May-22-24 11:15AM
May-20-24 08:12AM
May-19-24 01:17PM
May-16-24 10:34AM
May-15-24 04:05PM
09:17AM Loading…
May-13-24 09:17AM
May-10-24 07:01AM
May-09-24 07:00AM
May-07-24 02:45PM
May-06-24 04:05PM
May-03-24 03:31PM
03:12AM Loading…
May-02-24 10:30AM
May-01-24 09:15AM
Apr-30-24 08:15AM
Apr-29-24 11:13AM
Apr-26-24 04:17PM
Apr-25-24 04:01PM
07:00AM Loading…
Apr-22-24 07:00AM
Apr-18-24 06:46AM
Apr-09-24 09:02AM
Apr-08-24 07:00AM
Apr-04-24 08:11AM
Apr-01-24 07:00AM
Mar-22-24 09:48AM
Mar-14-24 11:30AM
Mar-12-24 07:51AM
Mar-11-24 07:00AM
Mar-07-24 07:00AM
Mar-06-24 05:01PM
Mar-05-24 08:23AM
Mar-01-24 08:39AM
Feb-28-24 07:00AM
Feb-26-24 05:00PM
Feb-17-24 02:00PM
Feb-16-24 04:05PM
Feb-15-24 09:07AM
Feb-14-24 10:03AM
Feb-13-24 09:30AM
Feb-12-24 12:10PM
Feb-07-24 07:00AM
Feb-06-24 04:05PM
Feb-05-24 07:00AM
Feb-01-24 10:00AM
Jan-30-24 01:36PM
Jan-29-24 10:41AM
Jan-25-24 07:00AM
Jan-23-24 08:00AM
Jan-16-24 11:22AM
Jan-11-24 12:10PM
Jan-05-24 08:05AM
Jan-04-24 08:00AM
Jan-03-24 04:35PM
Dec-27-23 07:34AM
Dec-20-23 11:32AM
Dec-19-23 09:41AM
Nov-28-23 07:50AM
Nov-27-23 09:15AM
Nov-20-23 04:15PM
Nov-07-23 09:00AM
Nov-06-23 07:18AM
Nov-04-23 01:25PM
Nov-02-23 09:18AM
Oct-27-23 11:07AM
Oct-26-23 10:02AM
Oct-20-23 12:10PM
Oct-12-23 08:13AM
Oct-05-23 08:32AM
Oct-04-23 08:47AM
Oct-03-23 07:00AM
Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The BSI BioSpin segment includes life science tools based on magnetic resonance technology. The BSI CALID segment focuses on life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions based on infrared and Raman molecular spectroscopy technologies and radiological and nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The BSI Nano segment offers advanced x-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments, analytical tools for electron microscopes and x-ray metrology, defect-detection equipment for semiconductor process control, handheld, portable, and mobile x-ray fluorescence spectrometry instruments, spark optical emission spectroscopy systems, and chip cytometry products and services for targeted spatial proteomics, multi-omics services, and products and services for spatial genomics research. The BEST segment is involved in superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research. The company was founded by Emil Bruker and Gunther Laukien in 1960 and is headquartered in Billerica, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Requardt Hermann FritzDirectorMar 04 '24Option Exercise22.0515,000330,75038,147Mar 06 04:05 PM
Requardt Hermann FritzDirectorMar 04 '24Sale90.0615,0001,350,89823,147Mar 06 04:05 PM
Busse FalkoPRESIDENT, BIOSPIN GROUPFeb 28 '24Option Exercise26.2828,122739,15660,981Mar 01 04:05 PM
Busse FalkoPRESIDENT, BIOSPIN GROUPFeb 28 '24Sale85.4828,1222,403,89032,859Mar 01 04:05 PM
Prause BurkhardPRES. & CEO, BRUKER BESTFeb 22 '24Option Exercise43.175,450235,29232,384Feb 26 04:02 PM
Prause BurkhardPRES. & CEO, BRUKER BESTFeb 22 '24Sale83.3015,3191,276,07317,065Feb 26 04:02 PM
LINTON WILLIAM ADirectorDec 05 '23Option Exercise19.0710,000190,70033,048Dec 07 04:01 PM
LAUKIEN FRANK HPRESIDENT & CEOOct 26 '23Option Exercise46.1459,5232,746,68938,327,911Oct 30 04:11 PM
LAUKIEN FRANK HPRESIDENT & CEOAug 08 '23Option Exercise47.8544,1502,112,57838,255,291Aug 10 05:09 PM
LAUKIEN FRANK HPRESIDENT & CEOAug 08 '23Sale64.8137,9472,459,34538,217,344Aug 10 05:09 PM
LAUKIEN FRANK HPRESIDENT & CEOJul 27 '23Option Exercise37.4268,4542,561,54938,249,088Jul 31 04:10 PM
Herman Gerald NEXECUTIVE VICE PRESIDENT, CFOJun 16 '23Sale75.4214,2421,074,13236,462Jun 20 04:31 PM